BEC HCl

精氨酸酶抑制剂
  • ≥98%
有货

库存信息

关闭

库存信息

关闭

库存信息

关闭
货号 (SKU) 包装规格 是否现货 价格 数量
B413875-5mg
5mg 现货 Stock Image
B413875-25mg
25mg 期货 Stock Image
B413875-100mg
100mg 现货 Stock Image

基本描述

英文别名 BCP25043 | BEC HCl | CS-5831 | (2R)-2-amino-3-(2-boronoethylsulfanyl)propanoic acid hydrochloride | BEC hydrochloride | A900880 | XIA63867 | AC-29891 | AKOS030632996 | (2R)-2-amino-3-(2-boronoethylsulfanyl)propanoic acid;hydrochloride | S-(2-Boronoethyl)-
规格或纯度 ≥98%
英文名称 BEC HCl
生化机理 盐酸溴乙酰胆碱是一种缓慢结合的竞争性精氨酸酶抑制剂,对精氨酸酶 II 和大鼠精氨酸酶 I 的Ki值分别为 0.31 μM (pH7.5)和 0.4-0.6 μM。
储存温度 -20°C储存,充氩
运输条件 超低温冰袋运输
产品介绍


Information

BEC HCl BEC HCl is a slow-binding, and competitive arginase inhibitor with K i of 0.31 μM (pH7.5) and 0.4-0.6 μM for Arginase II and rat Arginase I, respectively.


Targets

Arginase II ; rat Arginase I 0.31 μM(Ki); <0.6 μM(Ki)


In vitro

BEC causes significant enhancement of NO-dependent smooth muscle relaxation. In myocytes, BEC augments Ca(2+)-dependent NOS activity and NO production, and increases basal contractility. BEC also inhibits the proliferation of human pulmonary artery smooth muscle cells by decreasing the expression levels of cyclin D1 and CDK4, increasing the expression of p27, and partly reducing the phosphorylation of Akt and ERK.


In vivo

In mice with allergic inflammation (OVA/OVA), BEC enhances peribronchiolar and perivascular inflammation, leads to enhanced NF-κB DNA binding and NF-κB-dependent inflammatory gene expression, and causes an increase in the content of NOx. In rats with pulmonary arterial hypertension, BEC reduces the right ventricle systolic pressure.

AI解读

产品属性

ALogP -2.415
Rotatable Bond 6

名称和识别符

PubChem SID 504772680
IUPAC Name (2R)-2-amino-3-(2-boronoethylsulfanyl)propanoic acid;hydrochloride
INCHI InChI=1S/C5H12BNO4S.ClH/c7-4(5(8)9)3-12-2-1-6(10)11;/h4,10-11H,1-3,7H2,(H,8,9);1H/t4-;/m0./s1
InChi Key GHPYJLCQYMAXGG-WCCKRBBISA-N
Canonical SMILES B(CCSCC(C(=O)O)N)(O)O.Cl
Isomeric SMILES B(CCSC[C@@H](C(=O)O)N)(O)O.Cl
PubChem CID 91826515
分子量 229.49

化学和物理性质

溶解性 Solubility (25°C) In vitro DMSO: 45 mg/mL (196.08 mM); Water: 45 mg/mL (196.08 mM); Ethanol: 45 mg/mL (196.08 mM);
DMSO(mg / mL) Max Solubility 45
DMSO(mM) Max Solubility 196.0869755
Water(mg / mL) Max Solubility 45
Water(mM) Max Solubility 196.0869755
分子量 229.490 g/mol
XLogP3
氢键供体数Hydrogen Bond Donor Count 5
氢键受体数Hydrogen Bond Acceptor Count 6
可旋转键计数Rotatable Bond Count 6
精确质量Exact Mass 229.035 Da
单同位素质量Monoisotopic Mass 229.035 Da
拓扑极表面积Topological Polar Surface Area 129.000 Ų
重原子数Heavy Atom Count 13
形式电荷Formal Charge 0
复杂度Complexity 145.000
同位素原子数Isotope Atom Count 0
定义的原子立体中心计数Defined Atom Stereocenter Count 1
未定义的原子立体中心计数Undefined Atom Stereocenter Count 0
定义的键立体中心计数Defined Bond Stereocenter Count 0
未定义的键立体中心计数Undefined Bond Stereocenter Count 0
所有立体化学键的总数The total count of all stereochemical bonds 0
共价键合单元计数Covalently-Bonded Unit Count 2

安全和危险性(GHS)

技术规格说明书

Appearance(B413875) white to off white powder or chunks
Proton NMR spectrum Conforms to structure
Purity(HPLC) 98-100(%)

质检证书(CoA,COO,BSE/TSE 和分析图谱)

C of A & Other Certificates(BSE/TSE, COO):
输入批号以搜索分析图谱:

通过匹配包装上的批号来查找并下载产品的 COA,每批产品都进行了严格的验证,您可放心使用!

找到2个结果

批号(Lot Number) 证书类型 日期 货号
I2217270 分析证书 22-06-07 B413875
C2526237 分析证书 22-06-07 B413875

溶液计算器